Record High Revenue, Adjusted Income from Operations, and Net Income, Up 10.0%, 1.0%, and 1.5% Year-over-Year, Respectively[1 ...
Urges the Genco Board to Engage in Good Faith with Respect to Diana's Offer of $27.34 Per Share, Comprised of $24.80 in Cash and One Diana Share ATHENS, Greece, June 18, 2026 (GLOBE NEWSWIRE) -- Diana ...
Frost & Sullivan identifies significant growth opportunities across quantum technologies, edge integration, and the Internet of Battlefield Things ...
Filipino tennis sensation Alex Eala stunned world No. 2 Elena Rybakina of Kazakhstan 7-5, 6-4 to reach the quarterfinal round of the WTA 500 Berlin Open on Thursday (early Friday morning in Manila).
Enterprise AI platform recognized for enabling healthcare organizations to scale AI while maintaining HIPAA compliance and patient data protection ...
The District Court Munich, Germany (Landgericht München I) today ruled in favor of Infineon Technologies in two further of the patent infringement cases - specifically one based on a patent one based ...
Madison Pacific Properties Inc. (the Company), reports the voting results of the Annual General Meeting of its shareholders held June 18, 2026 in Vancouver, British Columbia.
Explore AI-powered quantitative trading tools through automated strategies designed to simplify participation in digital asset markets.
THE Metropolitan Manila Development Authority (MMDA) said it is intensifying citizen earthquake preparedness as it joined the second-quarter Nationwide Simultaneous Earthquake Drill on Thursday.
LunaLite Drone Show Technologies, in partnership with the Commissioner Maxwell B. Chambers and The City of Miramar, will present The Freedom Legacy Drone Show Experience on June 23 at Miramar Regional ...
A 1,183-kilowatt installation cuts plant electricity consumption by 35 per cent - the latest signal from a nearly five-decade Canadian manufacturer that sustainability and performance are the same inv ...
The US health department said on Thursday it was seeking updates to labels for testosterone replacement therapies after reviewing new clinical data and other evidence.